The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)

Clinical trial NCT02596347 · COMPLETED

Trial details

NCT number: NCT02596347
Sponsor: National Jewish Health
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Beryllium Disease (CBD)Beryllium Sensitization (BeS)

Start date: 2015-04-01
Primary completion: 2019-12-06
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.